Class IOngoing
B BRAUN MEDICAL INC recalls 0
Recall date · record updated Sep 16, 2026 · Source: U.S. Food and Drug Administration (openFDA drug enforcement)
Check your product against the names and codes above. The FDA enforcement record lists the recall as voluntary: firm initiated; it does not state a consumer remedy, so follow the firm’s notice or the FDA link.
- Company
- B BRAUN MEDICAL INC
- Reason
- Presence of Particulate Matter: particulate matter identified as iron oxide, inorganic material, cellulose cotton fiber or polystyrene
- Hazard
- FDA Class I: a reasonable probability that use or exposure will cause serious adverse health consequences or death (FDA definition).
- Who’s affected
- Nationwide within the United States
- Where
- Nationwide
- Official notice
- www.accessdata.fda.gov/scripts/ires/index.cfm?Event=99703…
Products
0.9% Sodium Chloride Injection, USP, 100 mL Partial Fill in 150 mL PAB Container, Sterile, Rx only, B. Braun Medical Inc., Bethlehem, PA 18018 USA, NDC 0264-1800-32.
Codes/lots: Lot #: J6B435, J6B444, J6B457, Exp Date: 30APR2027.Quantity: 201,472 total containerRecall no. D-0869-2026Class I
Update history
- First listed on OVERLOOKED from the official record.
When the agency expands or changes this recall, we update this page and log the change here.
Proof: raw official record (JSON) · fetched from FDA API
More Medicines & devices recalls
Medicines & devicesClass II
American Health Packaging recalls Metoclopramide Tablets
Presence of Foreign Tablets/Capsules
· FDA · Nationwide
Medicines & devicesClass II
Zydus Pharmaceuticals (USA) Inc recalls Hydrocortisone Sodium Succinate for Injection
Failed Impurities/Degradation Specifications.
· FDA · Nationwide
Medicines & devicesClass II
Teva Pharmaceuticals USA, Inc recalls Metoclopramide Tablets
Presence of Foreign Tablets/Capsules
· FDA · Nationwide